PMID: 9160283Apr 1, 1997Paper

Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: relevance to caloric restriction, exercise, and insulin sensitivity

Medical Hypotheses
M F McCarty

Abstract

The mitotic rate of stem cells is a major determinant of cancer risk. Insulin-like growth factors (IGFs) are virtually obligate stimulants of cell turnover in nearly every tissue. IGF activity is subject to rapid modulation by hepatic release of IGF binding protein-1 (IGFBP-1), a factor whose synthesis is suppressed by insulin and increased by glucagon. Up-regulation of IGFBP-1 production can be expected to decrease IGF activity and thereby diminish cancer risk. Measures that sensitize peripheral tissues to insulin, and thereby down-regulate insulin secretion, can be expected to increase IGFBP-1 synthesis, provided that they do not unduly sensitize hepatocytes as well. Prolonged aerobic exercise and caloric restriction also increase IGFBP-1 production. Since IGF-1 suppresses hepatic synthesis of sex hormone binding globulin (SHBG), down-regulation of IGF activity will increase SHBG levels and thus diminish the availability of free sex hormones--an effect that should further decrease cancer risk in sex hormone-responsive tissues. These considerations rationalize many findings in animal and epidemiologic studies, and suggest that non-diabetic insulin resistance may be a significant cancer risk factor. Increased IGF activity assoc...Continue Reading

References

May 10, 1975·Lancet·A R DyerE Stevens
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·W J PledgerC D Scher
May 1, 1977·The Journal of Clinical Endocrinology and Metabolism·M BinouxM Donnadieu
Mar 1, 1992·British Journal of Cancer·V M Macaulay
Nov 1, 1992·Journal of Gerontology·E J MasoroC A McMahan
Nov 1, 1992·Medicine and Science in Sports and Exercise·B Sternfeld
Jan 25, 1992·American Journal of Epidemiology·I M LeeC C Hsieh
Dec 1, 1990·The Journal of Clinical Endocrinology and Metabolism·D K Snyder, D R Clemmons
Aug 1, 1991·Molecular and Cellular Endocrinology·M S Lewitt, R C Baxter
Feb 15, 1992·The American Journal of Cardiology·R J BarnardS B Inkeles
Jan 31, 1991·Biochemical and Biophysical Research Communications·L LiuL Harel
Oct 25, 1991·Cancer·E RonJ F Fraumeni
Feb 1, 1991·The Journal of Clinical Endocrinology and Metabolism·S Ezzat, S Melmed
Sep 1, 1990·The American Journal of Clinical Nutrition·N K FukagawaK L Minaker
Nov 30, 1990·Biochemical and Biophysical Research Communications·R KoistinenM Seppälä
Jun 1, 1990·Diabetes Care·R W Stout
Feb 1, 1990·Annals of Internal Medicine·D V SchapiraC E Cox
Feb 21, 1990·Journal of the National Cancer Institute·R Ballard-BarbashW E Helsel
Jul 5, 1990·The New England Journal of Medicine·D RudmanD E Mattson
Sep 1, 1987·The Journal of Clinical Endocrinology and Metabolism·R C Baxter, C T Cowell
Feb 1, 1988·The Journal of Clinical Endocrinology and Metabolism·A M SuikkariM Seppälä
Dec 1, 1988·The Journal of Clinical Endocrinology and Metabolism·W H BusbyD R Clemmons

❮ Previous
Next ❯

Citations

Oct 14, 2008·Genes & Nutrition·S Starcke, G Vollmer
Dec 2, 2009·Cancer Causes & Control : CCC·Richard M MartinPål Romundstad
Jan 1, 2000·Journal of the American Aging Association·J A MattisonA Bartke
Aug 3, 2002·Environmental Health Perspectives·Robert Y S ChengLucy M Anderson
Mar 31, 2004·Sports Medicine·Martha L Slattery
Jan 30, 2007·Journal of Endocrinological Investigation·G A B LimaM R Gadelha
Sep 10, 2009·International Journal of Cancer. Journal International Du Cancer·Gerco HaarsPetra H M Peeters
Jul 21, 2004·Best Practice & Research. Clinical Endocrinology & Metabolism·Arlan RichardsonJames F Nelson
Mar 27, 2002·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·P Cohen
Apr 9, 2008·Acta Physiologica Hungarica·H NandeeshaL N Dorairajan
May 29, 2004·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·F GascónM A Castaño
Mar 21, 2019·Current Opinion in Oncology·Adeel KaiserChristopher D'Adamo
Aug 17, 2006·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Grazyna JasienskaPeter T Ellison
Aug 5, 2003·The Oncologist·Anne McTiernan
Oct 24, 2000·Proceedings of the Society for Experimental Biology and Medicine·A K GhoshalM C Archer
Jun 6, 2002·Medicine and Science in Sports and Exercise·Martha L Slattery, John D Potter
May 23, 2009·Medicine and Science in Sports and Exercise·Bradley C NindlJohn F Patton
May 13, 2005·Mechanisms of Ageing and Development·John PapaconstantinouDavid E Harrison
Aug 29, 2021·Journal of Medical Ultrasonics·Loreto B FerilKatsuro Tachibana

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.